Nutrition Status after 1 Month of Biliary Drainage for Malignant Biliary Stenosis
Abstract
Endoscopic biliary drainage is widely recognized as the gold standard treatment for tumor strictures. The aim of our retrospective study was to assess the impact of biliary drainage on patients` nutritional status. We examined data from patients who underwent successful endoscopic drainage at the IBN SINA University Hospital in Rabat, Morocco, between January 2019 and December 2022. All these parameters were assessed before and after 1 month of drainage. The mean age of 70 patients was 59.29 ± 13. Mean weight increased significantly from 53.03 ± 9.85 kg before drainage to 57.4 kg ± 10.03 after 1 month of drainage (P=0.000). Mean BMI after drainage was 19.8 ± 3.63 kg/m2, versus 18.06 kg/m2±3.65 before drainage (P=0.000). Severe undernutrition was significantly reduced, with 8.5% of patients presenting a normal diet. 84.3% of patients were vomit-free after 1 month of drainage. ALB levels increased (32.59 g/l ± 5.38 (P=0000)), while CRP levels decreased after 1 month of drainage (P=0.003). Total bilirubin also decreased after drainage (from 217 mg/l to 25.28 mg/l (P=0.000)). Our study demonstrates the effectiveness of treatment in improving patients' conditions, notably by alleviating disabling symptoms and restoring digestive functions. This improvement has a positive impact on patients' nutritional status and quality of life.
Keywords: tumor biliary stenosis, nutritional status, endoscopic biliary drainage, palliative treatment.
Full Text:
PDFReferences
PU L. Z., SINGH R., LOONG C. K., and DE MOURA E. G. Malignant Biliary Obstruction: Evidence for Best Practice. Gastroenterology Research and Practice, 2016, 2016: 3296801. https://doi.org/10.1155/2016/3296801
HIDALGO M. Pancreatic cancer. The New England Journal of Medicine, 2010, 362(17): 1605–1617. https://doi.org/10.1056/NEJMra0901557
RIZVI S., KHAN S. A., HALLEMEIER C. L., KELLEY R. K., and GORES G. J. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nature Reviews Clinical Oncology, 2018, 15(2): 95–111. https://doi.org/10.1038/nrclinonc.2017.157
LOKICH J. J., KANE R. A., HARRISON D. A., and MCDERMOTT W. V. Biliary tract obstruction secondary to cancer: management guidelines and selected literature review. Journal of Clinical Oncology, 1987, 5(6): 969–981. https://doi.org/10.1200/JCO.1987.5.6.969
PARASHER G., & LEE J. G. The Role of ERCP in Pancreatico-Biliary Malignancies. In: COTTON P. B. (ed.) Advanced digestive endoscopy: ERCP. Blackwell Publishing Ltd, Malden, Massachusetts, 2005: 120-141. https://doi.org/10.1002/9780470987490
STRASBERG S. M., GAO F., SANFORD D., LINEHAN D. C., HAWKINS W. G., FIELDS R., CARPENTER D. H., BRUNT E. M., and PHILLIPS C. Jaundice: an important, poorly recognized risk factor for diminished survival in patients with adenocarcinoma of the head of the pancreas. HPB, 2014, 16(2): 150–156. https://doi.org/10.1111/hpb.12094
BOULAY B. R., & BIRG A. Malignant biliary obstruction: From palliation to treatment. World Journal of Gastrointestinal Oncology, 2016, 8(6): 498–508. https://doi.org/10.4251/wjgo.v8.i6.498
SMITH A. C., DOWSETT J. F., RUSSELL R. C., HATFIELD A. R., and COTTON P. B. Randomised trial of endoscopic steriting versus surgical bypass in malignant low bileduct obstruction. The Lancet, 1994, 344(8938): 1655–1660. https://doi.org/10.1016/s0140-6736(94)90455-3
DEVIERE J., BAIZE M., DE TOEUF J., and CREMER M. Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage. Gastrointestinal Endoscopy, 1988, 34(2): 95–101. https://doi.org/10.1016/s0016-5107(88)71271-7
RYAN D. P., HONG T. S., and BARDEESY N. Pancreatic adenocarcinoma. The New England Journal of Medicine, 2014, 371(11): 1039–1049. https://doi.org/10.1056/NEJMra1404198
ALBORES-SAAVEDRA J., SCHWARTZ A. M., BATICH K., and HENSON D. E. Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program. Journal of Surgical Oncology, 2009, 100(7): 598–605. https://doi.org/10.1002/jso.21374
THOMAIDIS T., KALLIMANIS G., MAY G., ZHOU P., SIVANATHAN V., MOSKO J., TRIANTAFILLIDIS J. K., TESHIMA C., and MOEHLER M. Advances in the endoscopic management of malignant biliary obstruction. Annals of Gastroenterology, 2020, 33(4): 338–347. https://doi.org/10.20524/aog.2020.0497
CUI P., PANG Q., WANG Y., QIAN Z., HU X., WANG W., LI Z., ZHOU L., MAN Z., YANG S., JIN H., and LIU H. Nutritional prognostic scores in patients with hilar cholangiocarcinoma treated by percutaneous transhepatic biliary stenting combined with 125I seed intracavitary irradiation: A retrospective observational study. Medicine, 2018, 97(22): e11000. https://doi.org/10.1097/MD.0000000000011000
KONDUK B. T., YILDIZ T., DEMIRYUREK S., YILDIRIM A. E., BARUTCU S., ERDEM ER R., BALKAN A., and GULSEN M. T. Effects of Endoscopic Biliary Drainage on Proximal and Distal Malignant Biliary Obstructions. Acta Medica Mediterranea, 2019, 35: 211-215. https://doi.org/10.19193/0393-6384_2019_1_33
PADILLO F. J., MUNTANE J., MONTERO J. L., BRICEÑO J., MIÑO G., SOLORZANO G., SITGES-SERRA A., and PERA-MADRAZO C. Effect of internal biliary drainage on plasma levels of endotoxin, cytokines, and C-reactive protein in patients with obstructive jaundice. World Journal of Surgery, 2002, 26(11): 1328–1332. https://doi.org/10.1007/s00268-002-6232-9
ABRAHAM N. S., BARKUN J. S., and BARKUN A. N. Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointestinal Endoscopy, 2002, 56(6): 835–841. https://doi.org/10.1067/mge.2002.129868
BALLINGER A. B., MCHUGH M., CATNACH S. M., ALSTEAD E. M., and CLARK M. L. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut, 1994, 35(4): 467–470. https://doi.org/10.1136/gut.35.4.467
LUMAN W., CULL A., and PALMER K. R. Quality of life in patients stented for malignant biliary obstructions. European Journal of Gastroenterology & Hepatology, 1997, 9(5): 481–484. https://doi.org/10.1097/00042737-199705000-00013
SHERMAN S., LEHMAN G., EARLE D., LAZARIDIS E., FRAKES J., JOHANSON J., QASEEM T., and HOWELL D. Endoscopic palliation of malignant bile duct obstruction: Improvement in quality of life. Gastrointestinal Endoscopy, 1996, 43(4): 321. https://doi.org/10.1016/S0016-5107(96)80122-2
VAN LAETHEM J. L., DE BROUX S., EISENDRATH P., CREMER M., LE MOINE O., and DEVIÈRE J. Clinical impact of biliary drainage and jaundice resolution in patients with obstructive metastases at the hilum. The American Journal of Gastroenterology, 2003, 98(6): 1271–1277. https://doi.org/10.1111/j.1572-0241.2003.07504.x
CHEUNG K. L., & LAI E. C. Endoscopic stenting for malignant biliary obstruction. Archives of Surgery, 1995, 130(2): 204–207. https://doi.org/10.1001/archsurg.1995.01430020094018
BARKAY O., MOSLER P., SCHMITT C. M., LEHMAN G. A., FRAKES J. T., JOHANSON J. F., QASEEM T., HOWELL D. A., and SHERMAN S. Effect of endoscopic stenting of malignant bile duct obstruction on quality of life. Journal of Clinical Gastroenterology, 2013, 47(6): 526-531. https://doi.org/10.1097/MCG.0b013e318272440e
Refbacks
- There are currently no refbacks.
